Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats

Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats

Abstract Background Parasitic bronchopneumonia in domestic cats in Europe, which can manifest with moderate to severe clinical signs, is frequently caused by Troglostrongylus brevior. Data on epizootiological and clinical relevance of cat troglostrongylosis have been published in the last decade but...

Full description

Bibliographic Details
Main Authors: Donato Traversa, Katharina Raue, Hannah Ringeisen, Katrin Blazejak, Katrin Bisterfeld, Angela Di Cesare, Mariasole Colombo, Claudia Böhm, Christina Strube, Matthias Pollmeier
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Parasites & Vectors
Subjects:
Cat
Moxidectin
Treatment
Feline lungworms
Troglostrongylus brevior
Online Access:https://doi.org/10.1186/s13071-022-05185-y

Internet

https://doi.org/10.1186/s13071-022-05185-y

Similar Items